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Treatment Strategies for Hepatic Metastases
from Pancreatic Cancer in Patients Previously
Treated with Radical Resection Combined
with Intraoperative Radiation Therapy
HIROSHI TAKAMORI, TAKEHISA HIRAOKA, KEIICHIROU KANEMITSU, TATSUYA TSUJI,
NAOYUKI SAITO, HIDEFUMI NISHIDA, HISASHI SAKAGUCHI and YOSHIMASA MIYAUCHI
First Department of Surgery, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto, 860 Japan
Since 1984, we have performed extended radical resection combined with extended in-
traoperative radiation therapy (IORT) for pancreatic cancer. This approach has provided
a dramatic improvement in long-term survival and control of local recurrence. Hepatic meta-
stases, however, remain an unsolved problem. Among patients with this combined therapy, we
found hepatic metastases in 8 of 22 patients postoperatively. Four of these 8 were considered
candidates for further therapy and underwent treatment for their hepatic metastases, the other
4 had too extensive disease. Two patients with multiple hepatic metastases underwent per-
cutaneous ethanol injection therapy and chemotherapy, but they died within a year. Two
patients with a solitary hepatic metastases underwent hepatic resection. One patient died two
years and six months after the first operation because ofmultiple metastases in the liver and both
lungs, while the other patient is still alive over six years after the first operation with an excellent
performance status. When a patient has no local recurrence and a solitary metastasis in the liver,
surgical resection of the liver metastasis should be performed.
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INTRODUCTION
Carcinoma of the pancreas represents one of the most
challenging diseases faced by abdominal surgeons. The
long-term survival of patients following resection re-
mains poor 1. Even after radical resection, we very often
find local recurrences and hepatic metastases at au-
topsy.
In order to control local recurrence after radical
resection for pancreatic cancer, we have performed
extended radical pancreatectomy combined with in-
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traoperative radiation therapy (IORT) since 1984. The
five year cumulative survival rate of these patients was
33.3 percent. Four autopsies were permitted among 14
patients. Three of four autopsied cases showed no
evidence of local recurrences. This approach has pro-
vided a dramatic improvement in long-term survival
and control of local recurrence compared with other
therapies2.
Even after control of local recurrence by this com-
bined therapy, we have found hepatic metastases, these
have often been multiple and the patients have had
a poor prognosis. However one patient died with only
two localized liver metastases seen at autopsy in 1986.
Since that time we have taken surgical treatment for
patients with localized metastases into careful con-
sideration. We present a treatment strategy for such
hepatic metastases.
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PATIENTS AND METHODS
During the period from 1984 to 1992, we performed
extended radical resection combined with extended
IORT on 22 patients. As described previously2, this
combined therapy involves the dissection of the juxta-
regional and regional lymph nodes together with the
connective tissue around the aorta extending from the
diaphragm to the inferior mesenteric artery. Following
dissection and/or vascular reconstruction, a dose of
30Gy with 9MeV electron beam radiation was admin-
istered to the operative field including the paraaortic
area from the diaphragm to the inferior mesenteric
artery using a special applicator that could be varied in
size to accommodate the operative field on an individ-
ual basis. In this series, we found liver metastases in
8 patients after the operation. Four of these 8 patients
underwent treatment for their liver metastases, the
other 4 patients had multiple metastases in multiple
organs (Table 1).
VI of the liver. We performed percutaneous ethanol
injection therapy for this lesion, but the metastatic
lesion did not change over ten months, and no new
lesions appeared in the liver. Since no local recurrences
were detected, he underwent partial hepatectomy for
resection of the metastasis. The histopathological
diagnosis of this metastasis was a well differentiated
tubular adenocarcinoma with invasion into Glisson’s
sheath.ACT scan 17 months after the hepatic resection
revealed a new 3 cm low density area in the remnant
segment VI of the liver, but no evidence of any local
recurrences existed. Another partial hepatectomy was
performed. At surgery, the tumor was noted to have
invaded.into the right kidney, ascending colon, and
right diaphragm. We performed a partial resection of
these organs. By histopathology, the tumor was a well
differentiated tubular adenocarcinoma, indicating
metastases from the original pancreatic cancer. He has
recovered with an excellent performance status. He is
still alive over six years after the first operation.
CASE REPORTS
Case i
A 70-year-old man was diagnosed as having cancer of
the neck of the pancreas. He underwent the combined
therapy as described above. On histopathological
examination, the tumor was a stage III moderately
differentiated tubular adenocarcinoma (pT2, pN1,
pM0). At the margin of the resected specimen, cancer
cells were found histologically. This operation was
classified as a nonradical operation. A computed to-
mography (CT) scan 22 months after the operation
revealed a single 3 cm low density area in the segment
Case 2
A 58-year-old man was diagnosed as having cancer of
the head of the pancreas, and he underwent the com-
bined therapy already described. By histopathology,
the tumor was a stage III moderately differentiated
tubular adenocarcinoma (pT2, pN1, pM0). His oper-
ation was nonradical histologically because cancer
cells were observed at the resection margin of the
specimen. A CT scan one year and nine months after
the resection showed a low density area of 2 cm in
diameter in the segment VI of the liver, and a coin
lesion in the segment VI of the right lung. For the
hepatic metastasis, he underwent five cycles of per-
cutaneous ethanol injection therapy in six months, but
Table 1 Four patients receiving treatments for hepatic metastases
Case Treatment Hepatic Histologic Stage Prognosis
metastases radicality (p-TNM)
1. Partial hepatectomy 1. $6 non radical III alive
2. Partial hepatectorny 2. S (5 yr. 11 mon.)
2 PEIT 5 times S non radical III died
Partial hepatectomy multiple (2 yr. 6 mon.)
3 PEIT 2 times S,, radical III died
CDDP 100mg/Lip 10mL(HA*) multiple (6 mon.)
4 PElT 2 times $2,4 radical III died
multiple (11 mon.)
*Hepatic arterial injection was performed by Seldinger’s method.
PEIT percutaneous ethanol injection therapy; CDDP cisplatin; Lip lipiodol; HA hepatic arterial injectionHEPATIC METASTASES AFTER PANCREATECTOMY 109
the size of the tumor increased. No evidence of local
recurrence was present at that time, so a radical partial
resection of the liver and the right lung was performed
simultaneously. Pathological findings showed a mod-
erately differentiated tubular adenocarcinoma. A
CT scan two months later, however, revealed a coin
lesion in the upper lobe of the left lung, so he
underwent a radical partial resection of the left
lung. Two years and six months after the first oper-
ation, he died of multiple metastases in the liver
and both lungs.
Case 3
A 70-year-old man was diagnosed as having cancer of
the head of the pancreas, and he underwent the com-
bined therapy. The tumor was a stage III moderately
differentiated tubular adenocarcinoma (pT2, pN1,
pM0). This operation was classified as a radical oper-
ation histologically. ACT scan two months later
showed low density areas in liver segments IV and V.
Since it was not entirely clear whether these lesions
were well localized and therefore resectable, the patient
was treated with 2 cycles of percutaneous ethanol
injection therapy and an intra hepatic arterial injection
of cisplatin (100 mg/10 ml lipiodol) over a two-month
period. During this time, the size and number of these
tumors increased, and he died six months after the
operation.
Case 4
A 62-year-old man was diagnosed as having cancer of
the head of the pancreas, and he underwent the com-
bined therapy. By histopathology, the tumor was
a stage III moderately differentiated tubular adenocar-
cinoma (pT2, pN 1, pM0). This operation was classified
as a radical operation histologically. ACT scan five
months later showed multiple low density areas in
segments II and IV of the liver. These tumors were not
localized, so a resection was not performed. The pa-
tient received 2 cycles of percutaneous ethanol injec-
tion therapy. These therapies were not effective, and
number and size of the hepatic tumors increased. He
died 11 months.after the operation.
DISCUSSION
Despite recent advances in diagnostic and surgical
techniques for pancreatic cancer, the long-term sur-
vival of patients following resection remains poor.
Even following radical resection, a high ProPortion of
patients have local recurrence and hepatic metastases
at autopsy. Therefore, for prevention of local recur-
rence, intraoperative radiotherapy (IORT) was com-
bined with resection at the Kumamoto University
School of Medicine since 19763 However, the results
when .combined with conventional surgery have
proved disappointing. Extended radical resection has
been combined with extended IORT at our institute
since 1984. We have had a dramatic improvement
in long-term survival’and control of local recurrence
compared with other approaches2. Although cases
1 and 2 presented here had macroscopically com-
plete tumor clearance, cancer cells were found at the
resection margin of the specimen microscopically.
Local recurrence, however, was not detected clini-
cally after the combined therapy, indicating the effec-
tiveness of the intraoperative radiation. However,
this combined therapy did not prevent hepatic
metastases.
Hepatic metastases following a radical operation for
pancreatic cancer can fall into one of three patterns: 1)
postoperative hepatic metastases, probably due to sur-
gical manipulation, 2) one or more metastatic lesions
from local recurrence after resection, or 3) an erroneous
preoperative diagnosis. Whatever the cause, a strategy
for treating postoperative hepatic metastatic lesions
must be devised. In this series, we found one or more
hepatic metastases in 8 patients. Multiple hepatic
metastases occurred in 6 patients and they died within
a year. Therefore, a prudent approach is to observe the
patient for several months, perhaps treating with per-
cutaneous ethanol injection therapy, intra-hepatic ar-
terial chemotherapy, or nothing at all. The appearance
ofnew lesions during this time might make the patient
inoperable and unlikely to benefit from further surgery.
Although percutaneous ethanol injection therapy is an
effective treatment for hepatocellular carcinoma’, it
may not be effective for hepatic metastases from pan-
creatic cancer. One reason may be that it is too solid to
inject a sufficient volume of ethanol to induce necrosis
so it miy be necessary to inject it not only into the
lesions, but also into sites around metastases. In cases
ofmultiple hepatic metastases, our results indicate that
surgical resection is ineffective. In patients with a soli-
tary tumor, and no evidence of a local recurrence, in
good health and able to tolerate the operation, resec-
tion of the metastatic lesion may result in long term
survival.
Therefore, if local recurrence can be controlled by
a radical resection and intraoperative radiation
therapy, localized resectable hepatic metastases in the110 H. TAKAMORI et al.
post-operative period should be resected. This will
result in some long-term pancreatic cancer survivors.
Regarding the implantation and growth oftumor cells
released into the portal system, these may be promoted
during surgery because ofimmunosuppression and/or
impaired coagulation induced by surgical trauma. Im-
munochemotherapy may someday be useful for the
prevention of hepatic metastases. At present, however,
there is no effective treatment for this. We believe that
treatments designed to eliminate metastases in the liver
during the perioperative period will become an import-
ant component of an effective treatment protocol for
pancreatic cancer.
In conclusion, if patients with pancreatic cancer
have localized’ liver metastases after this combined
therapy and no local recurrence, their localized liver
metastases should be resected to improve their chances
for long-term survival.
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